CSIMarket
 


Aytu Biopharma Inc   (AYTU)
Other Ticker:  
 
 

AYTU's Capital Expenditures Growth by Quarter and Year

Aytu Biopharma Inc 's Capital Expenditures results by quarter and year




AYTU Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - 0.00 0.00 0.00
III Quarter March - 0.00 0.00 15.40
II Quarter December 0.00 0.00 0.00 0.00
I Quarter September 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.00 15.40



AYTU Capital Expenditures second quarter 2024 Y/Y Growth Comment
Aytu Biopharma Inc in the second quarter 2024 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the second quarter 2024, Aytu Biopharma Inc achieved the best Capital Expenditures growth in Major Pharmaceutical Preparations industry. While Aytu Biopharma Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the second quarter 2024.




AYTU Capital Expenditures ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - 1040.74 %
II Quarter December - - - -
I Quarter September - - - -
FY   - - - 163.25 %

Financial Statements
Aytu Biopharma Inc 's second quarter 2024 Capital Expenditures $ 0.00 millions AYTU's Income Statement
Aytu Biopharma Inc 's second quarter 2023 Capital Expenditures $ 0.00 millions Quarterly AYTU's Income Statement
New: More AYTU's historic Capital Expenditures Growth >>


AYTU Capital Expenditures (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - 163.25 %




Capital Expenditures second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Aytu Biopharma Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AYTU's II. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AYTU's II. Quarter Q/Q Capital Expenditures Comment


Aytu Biopharma Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Dec 31 2023 period, Aytu Biopharma Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Aytu Biopharma Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Dec 31 2023 period, Aytu Biopharma Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Aytu Biopharma Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
AYTU's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for AYTU's Competitors
Capital Expenditures Growth for Aytu Biopharma Inc 's Suppliers
Capital Expenditures Growth for AYTU's Customers

You may also want to know
AYTU's Annual Growth Rates AYTU's Profitability Ratios AYTU's Asset Turnover Ratio AYTU's Dividend Growth
AYTU's Roe AYTU's Valuation Ratios AYTU's Financial Strength Ratios AYTU's Dividend Payout Ratio
AYTU's Roa AYTU's Inventory Turnover Ratio AYTU's Growth Rates AYTU's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Stereotaxis Inc -0.81%$ -0.813 millions
Icon Plc-1.03%$ -1.033 millions
Abbvie inc -3.76%$ -3.756 millions
Vanda Pharmaceuticals Inc -3.80%$ -3.802 millions
Warby Parker Inc -4.52%$ -4.516 millions
Bristol myers Squibb Company-4.62%$ -4.624 millions
Baxter International Inc -5.00%$ -5.000 millions
Progyny Inc -5.55%$ -5.548 millions
Koru Medical Systems Inc-6.92%$ -6.916 millions
Ufp Technologies Inc -7.02%$ -7.018 millions
Bio rad Laboratories Inc -7.27%$ -7.272 millions
Endo International Plc-8.13%$ -8.130 millions
Eterna Therapeutics Inc -9.52%$ -9.524 millions
Sotera Health Company-9.63%$ -9.633 millions
Hutchmed china Limited-11.05%$ -11.052 millions
Petvivo Holdings Inc-11.46%$ -11.461 millions
Novartis Ag-11.52%$ -11.519 millions
Charles River Laboratories International inc -12.02%$ -12.020 millions
Surgery Partners Inc -12.78%$ -12.775 millions
Xbiotech Inc -12.88%$ -12.879 millions
Conmed Corporation-14.46%$ -14.464 millions
Msa Safety Incorporated-14.60%$ -14.601 millions
Teva Pharmaceutical Industries Limited-16.20%$ -16.197 millions
Genedx Holdings Corp -16.28%$ -16.279 millions
Dexcom Inc -17.32%$ -17.323 millions
Davita Inc -17.74%$ -17.739 millions
Voyager Therapeutics Inc -19.08%$ -19.078 millions
Natera inc -19.40%$ -19.405 millions
Capricor Therapeutics inc -19.51%$ -19.515 millions
Ardelyx Inc -21.82%$ -21.818 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com